Kisqali 600 MG daily dose UU 63S
Ended Awarded Last action
- Contract number
- SPE2DR26FDA2X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,560
Award facts
- Contract value 100% obligated
- $24,560.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,560 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Kisqali 600 mg daily dose tablets (63-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of February 9, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is a subsidiary of Cencora, Inc. The delivery order falls under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999.99 million through December 2026), which provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
Kisqali (ribociclib) is an oncology medication used in breast cancer treatment, reflecting the therapeutic diversity of products supplied through AmerisourceBergen's federal contracts. This delivery order exemplifies the routine pharmaceutical procurement conducted through the DLA's established vendor relationships, enabling rapid fulfillment of critical medical commodities needed across military treatment facilities and veteran healthcare programs. The firm fixed-price structure and compressed delivery timeline underscore the operational efficiency required in federal medical supply chains supporting active military and defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FDA2X?
SPE2DR26FDA2X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FDA2X worth?
The government has obligated $24,560 on SPE2DR26FDA2X.
Is contract SPE2DR26FDA2X an order under another contract?
Yes. SPE2DR26FDA2X is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDA2X competed?
The extent of competition for SPE2DR26FDA2X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award